Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

Viral Infections, Non-HIV

Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control

Clin Infect Dis.

Kamerlin SCL, Kasson PM

doi: 10.1093/cid/ciaa864.

Viral Infections, Non-HIV

GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic

Oncologist.

Martin M, Guerrero-Zotano A, Montero Á, Jara C, Filipovich E, Rojo F, Moreno F, García Sáenz JÁ, Alés JE, Chacón JI, Cruz J, Gimenez J, Cruz-Merino L, Algara M, Santisteban M, Tarruella SL, GEICAM Spanish Breast Cancer Group Steering Committee.

doi: 10.1634/theoncologist.2020-0363.

Viral Infections, Non-HIV

The Utah Model: mental bandwidth and strategic risk generation in COVID-19 airway management

Anaesthesia.

Runnels S, Ferranti D, Davis AN, Pollard J

doi: 10.1111/anae.15086.

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study

Swiss Med Wkly

Maximiano Sousa F, Roelens M, Fricker B, Thiabaud A, Iten A, Cusini A, Flury D, Buettcher M, Zukol F, Balmelli C, Zimmermann P, Troillet N, Vuichard-Gysin D, Schreiber PW, Bernhard-Stirnemann S, Tschudin-Sutter S, Nussbaumer-Ochsner Y, Sommerstein R, Gaudenz R, Marschall J, Senn L, Gardiol C, Keiser O, Schüpbach G, Wymann M, Vidondo B, Ch-Sur Study Group

doi: 10.4414/smw.2021.20547

Viral Infections, Non-HIV

Dynamic modelling to identify mitigation strategies for the COVID-19 pandemic

Swiss Med Wkly

Gorji H, Arnoldini M, Jenny D, Hardt WD, Jenny P

doi: 10.4414/smw.2021.20487

HIV / AIDSViral Infections, Non-HIV

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

Lancet HIV.

Vizcarra P, Pérez-Elías MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, Casado JL, COVID-19 ID Team.

doi: 10.1016/S2352-3018(20)30164-8.

Viral Infections, Non-HIV

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

J Natl Compr Canc Netw.

Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, McCreery B, Jagels B, Crane A, Byrd DR, Pergam SA, Davidson NE, Liu C, Stewart FM

doi: 10.6004/jnccn.2020.7560.

Viral Infections, Non-HIV

COVID-19 pandemic - A focused review for clinicians

Clin Microbiol Infect.

Cevik M, Bamford C, Ho A

doi: 10.1016/j.cmi.2020.04.023.

Related content

Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control

GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic

The Utah Model: mental bandwidth and strategic risk generation in COVID-19 airway management

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study

Dynamic modelling to identify mitigation strategies for the COVID-19 pandemic

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

COVID-19 pandemic - A focused review for clinicians